PROGRESS OF DEVELOPMENT

Disclosuring of information after Phase 1

DrugIndicationStatus (Region)
Difluprednateinflammation associated with ocular surgery, UveitisApproved (Russia)
SJP-0132Dry eyeP3(Japan)
SJP-0135GlaucomaP3(Japan)
SJP-0008Central Retinal Artery Occlusion (CRAO)P3(Japan)
PranoprofeninflammationApplication under review (Vietnam)
As of Apr. 2024